FIRAPY Forum 2025 – Holistic Care for Dialysis Patients: Makes Life Better

November 28, 2025

We are pleased to share that the FIRAPY Study Club will host its first international FIRAPY Forum on December 6, 2025 (Saturday), in conjunction with APCN × TSN 2025 in Taipei. The Forum will take place from 13:30–16:15, Room 603, 6F, Taipei Nangang Exhibition Center, Hall 2 (TaiNEX 2).

Under the theme “Holistic Care for Dialysis Patients: Makes Life Better,” the Forum will bring together nephrology experts from Taiwan, Japan, Korea, Malaysia, Thailand, and Indonesia to share the latest scientific evidence and real-world experience in far-infrared therapy (FIR therapy) for dialysis patients—covering vascular access care, dialysis management, and long-term outcome improvement.

We are deeply honored that WS FAR IR Medical is serving as a sponsor of the FIRAPY Forum. Together with our partners, we are also supporting Booth A38 in the APCN exhibition area as the Forum reception point, where participants can pre-register, ask questions, and continue discussions with the Secretariat team throughout the congress. 


How to Join

Date: December 6, 2025 (Saturday)

Time: 13:30–16:15

Venue: Room 603, 6F, Taipei Nangang Exhibition Center, Hall 2 (TaiNEX 2), Taipei

Registration: Free entry with pre-registration at Booth A38 in the APCN exhibition area



We warmly invite all colleagues attending APCN × TSN 2025 who are interested in dialysis care, vascular access, and non-invasive supportive therapies to join us at the FIRAPY Forum 2025.



Come meet the experts, hear the latest FIR evidence, and explore how FIRAPY can contribute to better vascular access, better dialysis care, and better lives for patients.

Want to know more?



Contact us for more detail


Learn more
Questions to FIRAPY
August 19, 2026
A new study published in Cells has provided further insight into the molecular responses of arterial endothelial cells following far-infrared (FIR) irradiation.  The study, conducted by researchers from Gunma Paz University, Japan, investigated the effects of FIR on human femoral artery endothelial cells (HFAECs) using an integrated multi-omics approach combining transcriptomics, proteomics, and phosphoproteomics. FIR irradiation was delivered using the WSTM TY101F far-infrared therapy unit manufactured by WS Far Infrared Medical Technology.
FIRAPY at MEDICA 2026 | Innovative Care for Dialysis Patients
August 19, 2026
Meet FIRAPY at MEDICA 2026 in Düsseldorf, November 16–19. Visit Hall 16, Booth B03-2 to explore innovative far infrared therapy for dialysis patient care.
More Posts